A leading AI-powered digital health platform for women, Flo Health, has secured over $200 million in series C funding from General Atlantic to accelerate its growth and expansion of service offerings to millions worldwide.
Co-founded by Dmitry Gurski in 2015, the company’s latest funding has driven its valuation to over $1 billion, making it the first fully women-focused digital health platform to attain unicorn status.
Flo Health’s platform supports women throughout their health journeys— from menstruation to conception, pregnancy, and menopause. It leverages its AI-enabled all-in-one platform, backed by over 120 doctors, experts, and other healthcare professionals, to offer ovulation, cycle tracking, and personalized health insights.
Additionally, the platform allows users to track and monitor more than 70 symptoms and access advanced features designed to enhance their understanding of their health and how to best manage it.
The platform users can also enjoy personalized health insights, tailored expert tips, daily health-focused visual content, and all-time access to private digital discussions centered on women’s health and wellness.
In 2023, Flo Health launched ‘Flo for Partners,’ a digital feature that aimed to empower users’ partners with scientific knowledge and insights to help them better understand their women’s menstrual and reproductive health.
According to the details of the latest funding, which was announced via a press release, the new partnership will help the femtech company accelerate the growth and expansion of its services into perimenopause and menopause, enhance its tech platform, and pursue strategic expansion opportunities.
Since its founding, the company has exhibited an impressive growth curve, reaching 70 million monthly active users as of 2024, far beyond the 60 million anticipated by 2027, with over 5 million paid subscribers.
